0001609550False00016095502024-05-072024-05-07


SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________
FORM 8-K
_________________________
CURRENT REPORT

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): May 7, 2024
_________________________
INSPIRE MEDICAL SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
_________________________
Delaware001-3846826-1377674
(State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
5500 Wayzata Blvd., Suite 1600
Golden Valley, Minnesota 55416
(Address of principal executive offices) (Zip Code)

(844) 672-4357
(Registrant’s telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 par value per shareINSPNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company     

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.07.    Submission of Matters to a Vote of Security Holders.
On May 2, 2024, Inspire Medical Systems, Inc. (the “Company”) held its annual meeting of stockholders. A total of 28,309,150 shares of the Company’s common stock were represented in person or by proxy at the meeting, representing approximately 95.44% of the Company’s common stock outstanding as of the March 5, 2024 record date. The following are the voting results for the proposals considered and voted upon at the meeting, each of which were described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on March 19, 2024.
Proposal 1 — Election of Directors
The following director nominees were elected as Class III directors to hold office until the Company’s annual meeting of stockholders to be held in 2027 and until their respective successors have been duly elected and qualified. The number of votes cast for and withheld from each nominee and the number of broker non-votes with respect to each nominee were as follows:
Votes FORVotes WITHHELDBroker Non-Votes
Shelley G. Broader26,330,635413,4521,565,063
Myriam J. Curet, M.D.23,526,1023,217,9851,565,063
Casey M. Tansey26,140,792603,2951,565,063
Proposal 2 — Ratification of Appointment of Independent Registered Public Accounting Firm
The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024 by voting as follows:
Votes FORVotes AGAINSTVotes ABSTAINEDBroker Non-Votes
27,471,018833,3204,812
Proposal 3 — Approval, on an Advisory (Non-Binding) Basis, of the Compensation of the Company's Named Executive Officers
The Company’s stockholders approved, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers by voting as follows:
Votes FORVotes AGAINSTVotes ABSTAINEDBroker Non-Votes
25,906,913670,207166,9671,565,063

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

INSPIRE MEDICAL SYSTEMS, INC.
Date:May 7, 2024By:/s/ Bryan K. Phillips
Bryan K. Phillips
Sr. Vice President, General Counsel and Secretary

3
v3.24.1.u1
Document and Entity Information
May 07, 2024
Cover [Abstract]  
Entity Registrant Name INSPIRE MEDICAL SYSTEMS, INC.
Entity Central Index Key 0001609550
Document Type 8-K
Amendment Flag false
Document Period End Date May 07, 2024
Entity Incorporation, State or Country Code DE
Entity File Number 001-38468
Entity Tax Identification Number 26-1377674
Entity Address, Address Line One 5500 Wayzata Blvd.
Entity Address, Address Line Two Suite 1600
Entity Address, City or Town Golden Valley
Entity Address, State or Province MN
Entity Address, Postal Zip Code 55416
City Area Code 844
Local Phone Number 672-4357
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol INSP
Security Exchange Name NYSE
Entity Emerging Growth Company false

Inspire Medical Systems (NYSE:INSP)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 Inspire Medical Systems 차트를 더 보려면 여기를 클릭.
Inspire Medical Systems (NYSE:INSP)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 Inspire Medical Systems 차트를 더 보려면 여기를 클릭.